Effects of flecainide and quinidine on action potential and ventricular arrhythmogenic properties in Scn3b knockout mice

Clinical and Experimental Pharmacology and Physiology

Volumn 37, Issue 8, 2010, Pages 782-789

  Hakim, Parvez ^a   Thresher, Rosemary ^a   Grace, Andrew A ^a   Huang, Christopher L H ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

flecainide; quinidine; Scn3b; sodium channel; ventricular arrhythmias

Indexed keywords

FLECAINIDE; QUINIDINE;

ACTION POTENTIAL; ANIMAL TISSUE; ARRHYTHMOGENESIS; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; ENDOCARDIUM; EPICARDIUM; HEART; HEART VENTRICLE TACHYCARDIA; KNOCKOUT MOUSE; MOUSE; NONHUMAN; WILD TYPE;

ACTION POTENTIALS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; ELECTRIC STIMULATION; ENDOCARDIUM; FLECAINIDE; MICE; MICE, KNOCKOUT; PERICARDIUM; QUINIDINE; REFRACTORY PERIOD, ELECTROPHYSIOLOGICAL;

EID: 77955103931     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2010.05369.x     Document Type: Article

References (32)

1. Isom LL. Sodium channel beta subunits: Anything but auxiliary. Neuroscientist 2001 7:42 54.
2. Ruan Y, Liu N, Priori SG. Sodium channel mutations and arrhythmias. Nat. Rev. Cardiol. 2009 6:337 348.
3. Papadatos GA, Wallerstein PM, Head CE et al. Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a. Proc. Natl. Acad. Sci. USA 2002 99:6210 6215.
4. Nuyens D, Stengl M, Dugarmaa S et al. Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome. Nat. Med. 2001 7:1021 1027.
5. Head CE, Balasubramaniam R, Thomas G et al. Paced electrogram fractionation analysis of arrhythmogenic tendency in DeltaKPQ Scn5a mice. J. Cardiovasc. Electrophysiol. 2005 16:1329 1340.
6. +/- murine hearts modelling the Brugada syndrome. J. Physiol. 2007 581:255 275.
7. +/Delta murine hearts modelling long QT syndrome 3. J. Physiol. 2007 578:69 84.
8. Killeen MJ, Thomas G, Gurung IS et al. Arrhythmogenic mechanisms in the isolated perfused hypokalaemic murine heart. Acta Physiol. (Oxf) 2007 189:33 46.
9. Thomas G, Killeen MJ, Gurung IS et al. Mechanisms of ventricular arrhythmogenesis in mice following targeted disruption of KCNE1 modelling long QT syndrome 5. J. Physiol. 2007 578:99 114.
10. Hothi SS, Booth SW, Sabir IN et al. Arrhythmogenic substrate and its modification by nicorandil in a murine model of long QT type 3 syndrome. Prog. Biophys. Mol. Biol. 2008 98:267 280.
11. Sabir IN, Fraser JA, Killeen MJ, Grace AA, Huang CL. The contribution of refractoriness to arrhythmic substrate in hypokalemic Langendorff-perfused murine hearts. Pflugers Arch. 2007 454:209 222.
12. Brugada R. Use of intravenous antiarrhythmics to identify concealed Brugada syndrome. Curr. Control Trials Cardiovasc. Med. 2000 1:45 7.
13. Brugada R, Brugada J, Antzelevitch C et al. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation 2000 101:510 515.
14. Windle JR, Geletka RC, Moss AJ, Zareba W, Atkins DL. Normalization of ventricular repolarization with flecainide in long QT syndrome patients with SCN5A: DeltaKPQ mutation. Ann. Noninvasive Electrocardiol. 2001 6:153 158.
15. Alings M, Dekker L, Sadee A, Wilde A. Quinidine induced electro-cardiographic normalization in two patients with Brugada syndrome. Pacing Clin. Electrophysiol. 2001 24:1420 1422.
16. Belhassen B, Glick A, Viskin S. Efficacy of quinidine in high-risk patients with Brugada syndrome. Circulation 2004 110:1731 1737.
17. Hu D, Barajas-Martinez H, Burashnikov E et al. A mutation in the beta-3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype. Circ. Cardiovasc. Genet. 2009 2:270 278.
18. Hakim P, Gurung IS, Pedersen TH et al. Scn3b knockout mice exhibit abnormal ventricular electrophysiological properties. Prog. Biophys. Mol. Biol. 2008 98:251 266.
19. Saumarez RC, Grace AA. Paced ventricular electrogram fractionation and sudden death in hypertrophic cardiomyopathy and other non-coronary heart diseases. Cardiovasc. Res. 2000 47:11 22.
20. Balasubramaniam R, Grace AA, Saumarez RC, Vandenberg JI, Huang CL-H. Electrogram prolongation and nifedipine-suppressible ventricular arrhythmias in mice following targeted disruption of KCNE1. J. Physiol. 2003 552:535 546.
21. Franz MR. Current status of monophasic action potential recording: Theories, measurements and interpretations. Cardiovasc. Res. 1999 41:25 40.
22. Knollmann BC, Katchman AN, Franz MR. Monophasic action potential recordings from intact mouse heart: Validation, regional heterogeneity, and relation to refractoriness. J. Cardiovasc. Electrophysiol. 2001 12:1286 1294.
23. Priori SG, Napolitano C, Schwartz PJ, Bloise R, Crotti L, Ronchetti E. The elusive link between LQT3 and Brugada syndrome: The role of flecainide challenge. Circulation 2000 102:945 947.
24. Hudson CJ, Whitner TE, Rinaldi MJ, Littmann L. Brugada electrocardiographic pattern elicited by inadvertent flecainide overdose. Pacing Clin. Electrophysiol. 2004 27:1311 1313.
25. Gussak I, Antzelevitch C, Bjerregaard P, Towbin JA, Chaitman BR. The Brugada syndrome: Clinical, electrophysiologic and genetic aspects. J. Am. Coll. Cardiol. 1999 33:5 15.
26. Fujiki A, Usui M, Nagasawa H, Mizumaki K, Hayashi H, Inoue H. ST segment elevation in the right precordial leads induced with class IC antiarrhythmic drugs: Insight into the mechanism of Brugada syndrome. J. Cardiovasc. Electrophysiol. 1999 10:214 218.
27. Roden DM, Woosley RL, Primm RK. Incidence and clinical features of the quinidine-associated long QT syndrome: Implications for patient care. Am. Heart J. 1986 111:1088 1093.
28. Jackman WM, Friday KJ, Anderson JL, Aliot EM, Clark M, Lazzara R. The long QT syndromes: A critical review, new clinical observations and a unifying hypothesis. Prog. Cardiovasc. Dis. 1988 31:115 172.
29. Anno T, Hondeghem LM. Interactions of flecainide with guinea pig cardiac sodium channels. Importance of activation unblocking to the voltage dependence of recovery. Circ. Res. 1990 66:789 803.
30. Ramos E, O'Leary ME. State-dependent trapping of flecainide in the cardiac sodium channel. J. Physiol. 2004 560:37 49.
31. Antzelevitch C. The Brugada syndrome: Ionic basis and arrhythmia mechanisms. J. Cardiovasc. Electrophysiol. 2001 12:268 272.
32. Ju YK, Saint DA, Gage PW. Effects of lignocaine and quinidine on the persistent sodium current in rat ventricular myocytes. Br. J. Pharmacol. 1992 107:311 316.